Kura Oncology, Inc.KURANASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P18
Within normal range
vs 3Y Ago
-1.1x
Contraction
Streak
3 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-8.24%
Q3 2025-13.33%
Q2 2025-13.64%
Q1 2025-200.00%
Q4 202465.08%
Q3 2024-6.78%
Q2 20240.00%
Q1 2024-7.27%
Q4 2023-10.00%
Q3 20235.66%
Q2 2023-6.00%
Q1 2023-2.04%
Q4 20227.55%
Q3 2022-1.92%
Q2 2022-6.12%
Q1 20220.00%
Q4 20212.00%
Q3 20211.96%
Q2 2021-10.87%
Q1 2021-2.22%
Q4 2020-7.14%
Q3 2020-5.00%
Q2 20204.76%
Q1 2020-7.69%
Q4 2019-8.33%
Q3 20195.26%
Q2 2019-2.70%
Q1 201911.90%
Q4 2018-5.00%
Q3 201811.11%
Q2 20182.17%
Q1 2018-24.32%
Q4 20172.63%
Q3 20175.00%
Q2 2017-2.56%
Q1 2017-2.63%
Q4 2016-2.70%
Q3 2016-2.78%
Q2 20160.00%
Q1 201614.29%